Skip to main content

Patent Prosecution in Jordan.

Patent prosecution in Jordan involves a series of steps to obtain patent protection for an invention within the country. 

Here's an overview:

1. Patent Search: 

Begin by conducting a patent search to ensure your invention is novel and not already patented in Jordan. This can be done through the Jordanian Patent Office (JPO) or online databases.

2.Draft a Patent Application: 

Prepare a detailed patent application describing your invention's technical aspects, including drawings and claims. It's advisable to seek legal counsel or a patent attorney experienced in Jordanian patent law for assistance.

3.Filing the Application: 

Submit your patent application to the JPO. Ensure it complies with the required format and includes all necessary documentation. Pay the filing fees.

4. Examination: 

The JPO will examine your application to determine its patentability. This process may involve correspondence and amendments to the application if required.

5. Publication: 

Once the JPO approves your patent application, it will be published in the Official Gazette, allowing for public review and potential opposition.

6.Grant of Patent: 

If there are no objections or oppositions, and your application meets all requirements, the JPO will grant you a patent.

7.Maintenance and Annuities: 

To keep your patent in force, you must pay annual maintenance fees to the JPO.

8.Enforcement: 

If someone infringes on your patent rights in Jordan, you can take legal action through the Jordanian courts to enforce your rights and seek remedies.

9.International Considerations: 

If you plan to seek patent protection in multiple countries, consider filing under the Patent Cooperation Treaty (PCT) or other international agreements to simplify the process.

Note: 

Patent law is complex, and it's advisable to consult with a qualified patent attorney or agent familiar with Jordanian patent law to navigate the process effectively. Additionally, patent laws and procedures may change over time, so it's essential to check with the Jordanian Patent Office for the most up-to-date information.

Labels:

Comments

Post a Comment

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em
1 comment
Read more

Novo Nordisk settles with 2 Florida venders of compounded (Semaglutide)Ozempic:

Novo Nordisk settles with 2 Florida venders of compounded Ozempic: Novo Nordisk has arrived at private settlements with two Florida merchants of intensified forms of the uber blockbuster semaglutide therapies Ozempic and Wegovy, the organization said on Friday. In June of last year, Novo recorded brand name encroachment claims against five dealers of knockoff renditions of the GLP-1 medications, which have seen soaring interest to battle weight reduction. Ekzotica Corp's. Restorative Laser Experts Drug Spa in Miami and Effinger Wellbeing's Nuvida Rx Weight reduction in Tallahassee are the initial two organizations to have settled their cases. As indicated by long-lasting directive orders, the dealers will quit utilizing Novo reserve and have consented to reveal for a considerable length of time that intensified variants of the medications have not gone through the security and viability norms expected by the FDA for supported drugs. "The litigants' unlawful showcasing
Post a Comment
Read more

Hypertension-An Overview

INTRODUCTION: Systemic arterial hypertension is one of the strongest known modifiable risk factors for ischaemic heart disease, stroke, renal failure and heart failure. It remains poorly treated. As an asymptomatic disorder, people are understandably reluctant to accept adverse drug effects in addition to the inconvenience of long-term treatment. In this regard, modern drugs represent an enormous improvement. PATHOPHYSIOLOGY AND SITES OF DRUG ACTION Hypertension is occasionally secondary to some distinct disease. However, most patients with persistent arterial hypertension have essential hypertension. Arterial blood pressure is determined by cardiac output, peripheral vascular resistance and large artery compliance. Peripheral vascular resistance is determined by the diameter of resistance vessels (small muscular arteries and arterioles) in the various tissues. One or more of a ‘mosaic’ of interconnected predisposing factors (including positive family history, obesity and phys
Post a Comment
Read more